T1	Participants 208 280	groups of 20, 60 women were randomly assigned to one of three treatments
T2	Participants 552 587	Patients who received calcium alone
T3	Participants 815 845	both clodronate-treated groups
T4	Participants 984 1025	patients treated with cyclical clodronate
T5	Participants 1068 1094	those treated continuously
T6	Participants 1205 1245	both in subjects treated with clodronate
T7	Participants 1252 1279	cyclically and continuously
T8	Participants 1305 1314	controls.
